![]() Some people have had serious infections of their lungs while taking OPZELURA. Some people have been hospitalized or died from these infections. Some people have had serious infections while taking JAK inhibitors by mouth, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. JAK inhibitors can lower the ability of your immune system to fight infections. JAK inhibitors are medicines that affect your immune system. Ruxolitinib belongs to a class of medicines called Janus kinase (JAK) inhibitors. Serious Infections: OPZELURA contains ruxolitinib. OPZELURA may cause serious side effects, including: Do not use OPZELURA in your eyes, mouth, or vagina. Incyte reserves the right to rescind, revoke, or amend this offer at any time without notice.įor questions or additional support call 833-613-2333 or email. Incyte may also de-identify the patient’s information and use the de-identified information for Incyte’s business purposes Incyte may also share the patient’s information with its subsidiaries, affiliates, representatives, agents, and contractors. By enrolling in this copay savings program, the patient acknowledges that Incyte may use their information and share it with providers or their insurance plan in connection with providing copay savings support and for the other purposes related to the copay savings program.Data related to the patient’s redemption of the copay savings card may be collected, analyzed, and shared with Incyte or its affiliates for market research and other purposes related to assessing Incyte’s programs.Offer valid only for an FDA-approved use.The copay savings card benefit may not be redeemed more than once per 25 days per patient. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |